Key Takeaways: How Regulatory Exclusivity, PTA, PTE, and Double Patenting Shape Pharmaceutical Lifecycle Value

Pharmaceutical lifecycle value is often at its highest towards the end of the patent term. With longer development timelines and potential patent challenges, life sciences companies must understand how FDA regulatory exclusivities,... By: Sterne, Kessler, Goldstein & Fox P.L.L.C.